Title:
【発明の名称】パピローマウィルスに基づく医薬品
Document Type and Number:
Japanese Patent JPH08508728
Kind Code:
A
Abstract:
PCT No. PCT/GB94/00683 Sec. 371 Date Jan. 24, 1996 Sec. 102(e) Date Jan. 24, 1996 PCT Filed Mar. 31, 1994 PCT Pub. No. WO94/23037 PCT Pub. Date Oct. 13, 1994The invention provides pharmaceutical formulations for Immunizing against papillomavirus tumors or lesions. Formulations may be selected from the group consisting of: (i) a formulation which comprises a papillomavirus (PV) L2 protein or fragment thereof that is effective to provide a protective effect to lessen the occurrence and severity of lesions or tumors caused by PV infection and an aluminum compound; (ii) a formulation which comprises a bovine papillomavirus (BPV) L2 protein or said fragment thereof and an aluminum compound: (iii) a formulation which comprises a BPV4 L2 protein or said fragment thereof and an aluminum compound; (iv) a formulation which comprises a BPV-4 protein or said fragment thereof and an adjuvant; (v) a formulation which comprises a BPV-4 L2 protein or said fragment thereof and an adjuvant; and (vi) a formulation which comprises a BPV4 protein or said fragment thereof and an aluminum compound.
Inventors:
Campo, Maria Severia
Jarrett, William Fleming Hogan
Jarrett, William Fleming Hogan
Application Number:
JP52183894A
Publication Date:
September 17, 1996
Filing Date:
March 31, 1994
Export Citation:
Assignee:
Cancer Research Campaign Technology Limited
International Classes:
C12N15/09; A61K38/45; A61K39/23; A61P31/12; C07K14/015; C07K14/025; C12N15/37; C12P21/02; A61K39/00; C12R1/19; (IPC1-7): A61K39/23; A61K38/45; C07K14/015; C12N15/09; C12P21/02
Attorney, Agent or Firm:
Takashi Ishida (3 others)